Live Breaking Biotech News and Articles

Biotech News Journal

Subscribe to Biotech News Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Biotech News Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

Top Stories

DALLAS, Aug. 21, 2014 /PRNewswire-iReach/ -- Amid the proliferation of real time data from sources such as mobile devices, web, social media, sensors, log files and transactional applications, Big Data has found a host of vertical market applications, ranging from fraud detection to R&D. Photo - "Big Data Market: 2014 – 2020 – Opportunities, Challenges, Strategies, Industry Verticals & Forecasts" Key Findings: In 2014 Big Data vendors will pocket nearly $30 Billion from hardware, software and professional services revenues Big Data investments are further expected to grow at a CAGR of nearly 17% over the next 6 years, eventually accounting for $76 Billion by the end of 2020 The market is ripe for acquisitions of pure-play Big Data startups, as competition heats up between IT incumbents Nearly every large scale IT ven... (more)

Technology Heroes Also Serve in Government

Great American technologists from academia and industry have always ensured our national security has the edge it needs, in peace, crisis and war. Academic Fredrick Terman (pictured) brought us radar and Silicon Valley. Edwin Land brought us overhead ISR. Gordon Moore ensured integrated circuits were accelerated into our community first. Scott McNealy drove security into Operating Systems. Bill Gates and Larry Ellison and a long list of other great IT leaders have also dedicated significant effort to the national security community in ways many will never know. Great technology heroes also serve in government.  Thanks to them government has been pioneering advances in secure cloud computing, biometrics, IT security, collaboration, geospatial, visualization, remote sensing and collaboration. Government IT leaders routinely contribute to our nation’s understanding of... (more)

Another Run at the Whole Face-Tracking, Invasion of Privacy Thing

There's another piece out taking a look at the concerns and ramifications of the increasing use of biometric audience counting technologies in digital out of home networks, this time on Digital Signage Expo's news portal. It's a good, balanced piece that takes very little of the alarmist tone from others I have read here and there in the past, and is by the same guy, Harley Geiger, who did a piece for the CBS News website a few weeks back. I wrote about that piece and it is referenced in this new article. I'm not sure I condemned privacy concerns, as suggested, but whatever ... Geiger suggests all companies using the technology, not just the vendors, should be upfront about what they are doing: A published privacy policy is an important move, but companies should take other steps as well. Consumers should be notified when digital signage units are using measurement ... (more)

TIBCO Spotfire in Life Sciences

Oracle Keynote at Cloud Expo October 19, 2009 - TIBCO Software announced a strategic push to extend its leadership position in the global life sciences market with the release of several research and clinical analysis solutions, including Integromics Biomarker Discovery 2.0 for TIBCO Spotfire, TIBCO Spotfire Lead Discovery 2.0, TIBCO Spotfire Pipeline Pilot Connector, and TIBCO Spotfire Clinical Graphics 2.0. These solutions deliver integrated informatics and analysis, are central to research & development efforts in the life sciences industry and can transform the process of bringing life-saving medicines to market. Access to actionable knowledge early in the commercialization process of a new drug can lead to better safety outcomes for patients, and better regulatory and commercial outcomes for the industry. The TIBCO Spotfire Enterprise Analytics Platform is de... (more)

John Wilbanks on Making Science Generative

John Wilbanks of Creative Commons (and head of Science Commons) is giving a Berkman lunchtime talk about the threats to science’s generativity. He takes Jonathan Zittrain’s definition of generativity: “a system’s capacity to produced unanticipated change through unfiltered contributions from broad and varied audiences.” NOTE: Live-blogging. Getting things wrong. Missing points. Omitting key information. Introducing artificial choppiness. Over-emphasizing small matters. Paraphrasing badly. Not running a spellpchecker. Mangling other people’s ideas and words. You are warned, people. [NOTE: Ethan Zuckerman has posted his far superior bloggage] ScienceCommons tries to spark the sort of creativity and innovation in science that we find in the broader cultural Net. Scientists often resist the factors that have increased generativity in other realms: Science isn’t very ac... (more)

Forecasting the Future of IT Is Scary

On December 16, 2013, our friends over at Compare the Cloud wrote a blog called “The Day Computing Changed Forever – and We All Missed it.” The blog centered on what the future of the Cloud could hold for society. Ironically enough, the post was published on the same day that Google (pictured below) announced it’s new line of products – four legged military machines. SkyNet anyone? Anyway, in the post our friends over at Compare the Cloud set the stage for what the future of the Cloud and IT in general could look like. From operating in the world via customized avatars, to fitting an entire data center within the space of a few specs of DNA to human clusters providing science with answers beyond current imagination, our friends at Compare the Cloud lay out a very interesting vision for the future. That said, we are going to use this space to, point-by-point, decon... (more)

PAREXEL Simplifies Drug Development Journey From Science To New Treatments

BOSTON, Feb. 12, 2014 /PRNewswire/ -- As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments. Drug development today is a demanding and difficult process. Increasingly, pharmaceutical companies are under pressure to accelerate development and introduce innovative new medicines and treatments in an increasingly complex and competitive environment. To assist in these efforts, companies are seeking a partner that can help simplify and accelerate all aspects of product development. "In today's market, biopharmaceutical companies ... (more)

Aventir Biotech Launches New 510(k) Cleared Fecal Occult Blood Screen Test

CARLSBAD, CA -- (MARKET WIRE) -- 07/17/07 -- Aventir Biotech's ForSure® Fecal Occult Blood (FOB) Screen Card Test has just been cleared for both over-the-counter and professional applications by the FDA, making it readily available for convenient and hygienic detection of possible Colorectal Carcinoma, Crohn's Disease, Ulcerative Colitis, and Colon Polyps in humans. Colorectal cancer is the second leading cause of cancer-related death for men and women. Aventir's innovative product will meet the growing needs of improved sample collection and testing accuracy for diseases related to Colorectal Carcinoma. "We are very pleased to bring the ForSure® Fecal Occult Blood (FOB) Screen Card Test, the first licensed OTC product to the US market. Early detection of the disease will help dramatically reduce healthcare costs across the nation," stated Jerry Lee, Marketing Dire... (more)

Hubspan Presents: "Integration as a Service: Are You Connected?"

SEATTLE, WA -- (MARKET WIRE) -- 08/07/07 -- Hubspan, Inc., a leading provider of solutions that connect businesses to their trading partners today announced the availability of a free on-demand webcast titled, "Integration as a Service: Are you connected?" accessible at In today's competitive environment, it's not enough to have the best products at the best prices, best-in-class organizations are seeking ways to also be the easiest to do business with. Connecting to clients despite differences in business processes and systems through Integration-as-a-Service can drive top line revenue, improve profitability, and increase customer satisfaction This innovative approach to B2B integration allows both large and mid-size companies to quickly, easily, and cost effectively improve the flow of operations within a trading community. In this free on-de... (more)

BioTech Medics, Inc. Enters Strategic Alliance With Digital Kinematics, Inc.

DALLAS, TX -- (MARKET WIRE) -- 11/08/07 -- BioTech Medics, Inc. (PINKSHEETS: BTME) announced today the signing of a Strategic Alliance with Digital Kinematics (DKI) of Dallas. The purpose of the Strategic Alliance is for both companies to work together in designing and engineering an exclusive digitized human motion software program to be used with the BioTech high-powered therapeutic medical lasers to detect pain related abnormalities in patient movements. The initial DKI product will consist of wireless sensors that can be programmed by either the doctor, laser technician or a physical therapist to be placed upon the patient to detect various motions made by the patient. When a patient comes to see a BioTech doctor or chiropractor with a pain related problem due to improper motion such as carpal tunnel syndrome, football, soccer, baseball, golf or tennis injury, ... (more)

Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting

Collaboration with Noted Neurologists to Plan Next Clinical Studies OMAHA, Neb. and HOUSTON, May 11 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM), announced the clinical introduction of the NuroPro(R) AD and NuroPro(R) PD tests for Alzheimer's and Parkinson's disease at the 2009 American Academy of Neurology meeting in Seattle, WA. The NuroPro tests help clinicians distinguish patients with Alzheimer's and Parkinson's diseases from "normal" individuals and patients with other neurological disorders. The tests, developed by Power3, are a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability a patient has neurodegenerative disease. This information will help physicians make earlier diagnoses and recommend appropriate follow-up and tr... (more)